Seven steps: decide whether to bid; read the RFP as the sponsor's scoring template; write a one-page summary of fit; answer the technical questions for this molecule; give a timeline with its assumptions; name the team; and state quality and regulatory facts exactly. Then present, answer follow-up questions fast, and ask for a debrief if you lose.
The work before the RFP decides how fast and how well you answer: a proof library of approved capability text, case summaries, people and quality wording.
Step 1: Decide whether to bid
A proposal costs scientists' and project managers' time. Four questions decide whether to spend it:
- Fit: is the modality, scale and dosage form one you run today, or one you would be learning on the sponsor's molecule?
- Capacity and timeline: can you start when the sponsor needs, with the suites, equipment and people free?
- Relationship: do you know the sponsor's people, or is this an RFP you were added to late?
- Value: is the project worth the proposal effort, including the likely follow-on phases?
Step 2: Read the RFP as the sponsor's scoring template
Most sponsors send a structured RFP with sections for the technical scope, timeline, quality and regulatory questions, commercial terms and confidentiality, and they score responses against it. Answer every question, in their order, using their headings and their words. A response that reorganizes the sponsor's questions into the CDMO's preferred story makes the scorer hunt, and a scorer who hunts marks down. Where a question cannot be answered yet, say what you need to answer it and when.
Step 3: A one-page summary of fit
Open with a single page that a sourcing lead can forward: your understanding of the project in the sponsor's terms, why your capability fits this molecule and phase, the proposed timeline in one line, the named project lead, and the two or three points that set your proposal apart. No adjectives about your company; facts about this project.
Step 4: The technical approach for this molecule
Describe how you would develop, scale or manufacture this specific product: the process steps and where risk sits, the analytical methods and what they will need, the batches and their purpose, and the decisions the sponsor will be asked to make along the way. Reference comparable work without naming other sponsors unless they have given permission. Specific, honest risk descriptions build more trust than a plan with no risks in it.
Step 5: A timeline with its assumptions
Give a timeline by phase, with the assumptions it rests on stated plainly: when the sponsor delivers material and information, how long methods transfer takes, release testing durations, and the points where a result could change the plan. A timeline with visible assumptions is easier to approve and easier to defend later than an optimistic date with none.
Step 6: The named team
Name the project lead, the lead scientist and the quality contact, with a short description of comparable work each has done. Sponsors buy the people they will work with every week, and a proposal that names them persuades more than one that describes the organization. Make sure the people named are available for the project if it is awarded.
Step 7: Quality and regulatory statements, exactly as true
This section is read by the sponsor's quality team, who will check it during the audit. Under 21 CFR 207.77(a), registration of an establishment does not denote approval, and any representation creating an impression of approval because of registration is misleading and constitutes misbranding; write "FDA-registered", never "FDA-approved facility". The FDA's Drug Master Files page says DMFs are neither approved nor disapproved, so write "DMF on file" with its type. Claim a CEP only for the substances it covers, and describe your quality system against 21 CFR Part 211 or EU GMP with the inspections and certificates behind it, dated.
State inspection history as facts, including observations and how they were closed, in the form your quality team approves. An API supplier describes the substance and its specifications, never what the finished medicine treats.
Commercial terms
Price the work in the structure the sponsor asked for, separate what is fixed from what depends on results, name the assumptions behind each price, and state what triggers a change. A clear commercial section shortens negotiation; a vague one reopens it at the worst moment.
The proof library that makes this fast
Between RFPs, keep five things current, so each response is tailoring, with little written from scratch. If you draft with AI tools, keep a named person on every fact: CMI's 2027 research found 52% of B2B marketers say their organization has no policy on disclosing AI use and only 8% disclose it on every piece, and an AI-drafted capability claim that nobody checked is the kind a sponsor's auditor finds. Our guide to life science content marketing covers how the same library feeds your published content.
- Capability text for each modality, scale and site, approved by operations and quality.
- Case summaries written without sponsor names unless permission is on file.
- Team profiles for project leads, scientists and quality contacts, kept current.
- Quality and regulatory wording, approved and dated, including inspection history.
- Standard answers to the questions every sponsor asks (confidentiality, tech transfer, change control, supply continuity).
Presenting, follow-up questions and the visit
Short-listed responses usually lead to a presentation, written questions and a site visit or audit. Bring the named team, answer written questions within the time asked, and prepare the site as the proposal described it. Our guide to life science website design covers the pages a sponsor checks before the visit.
The debrief, every time
When a proposal is lost, ask for a debrief and record the reasons against the RFP's sections: price, timeline, technical approach, quality, team or relationship. Over a year, the debriefs show which capability pages, case summaries and team profiles to improve, and which RFPs to decline. Track proposals submitted, proposals won and the reasons, by modality.
If you want it built with you
PromotEdge International is an international strategy, technology, marketing and design company, and our delivery team is in India. Life science clients we have worked for include Kopran and Novozymes. That work was for their business in India and was delivered by our team there. Our life science marketing service page describes the work; your quality team approves every regulatory statement we draft. This guide is general information, not legal or regulatory advice.
Facts we rely on: see our company facts for what we state about ourselves and where each fact comes from.